Abbott India (BOM:500488) Buildings And Improvements : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Abbott India Buildings And Improvements?

Abbott India's annual buildings and improvements declined from Mar. 2022 (₹1,832 Mil) to Mar. 2023 (₹1,469 Mil) and declined from Mar. 2023 (₹1,469 Mil) to Mar. 2024 (₹0 Mil).

Abbott India Buildings And Improvements Historical Data

The historical data trend for Abbott India's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Buildings And Improvements Chart

Abbott India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Buildings And Improvements

Get a 7-Day Free Trial

2,053.60

1,862.00

1,831.90

1,469.00

Abbott India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															1,469.00	-	-	-	-

Abbott India Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Abbott India (BOM:500488) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

ABBOTINDIA:India

Address

15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.abbott.co.in

Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines